PGR Financial Facts
Net effect of dilutive stock-based compensation: 3.1MTotal expenses: 5.68B
See Full Income Statement
Net unrealized gains on forecasted transactions: -9.1M
Common equities (cost: $1,379.8, $1,005.1, and $1,021.7): 2.87B
See Full Balance Sheet
Progressive (PGR) Earnings
|
Expand Research on PGR
| Next EPS Date | 7/9/26 | EPS Growth Rate | -29.4% |
|---|---|---|---|
| Average EPS % Beat Rate | +6.2% | Revenue Growth Rate | +8.0% |
| Average % Move 1-Wk after EPS | -0.8% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 7/9/26 |
Q226 | N/A | $3.81 | N/A | N/A | $21.69B | N/A | N/A | N/A | ||
| 4/15/26 | Q126 | $4.80 | $4.83 | -$0.03 | $23.64B | $23.28B | N/A | ![]() | ![]() | Details | |
| 1/28/26 | Q425 | $5.02 | $4.43 | +$0.59 | $19.51B | $20.31B | N/A | ![]() | ![]() | Details | |
| 10/15/25 | Q325 | $4.45 | $5.05 | -$0.60 | $21.38B | $21.8B | N/A | ![]() | ![]() | Details | |
| 7/16/25 | Q225 | $5.40 | $4.36 | +$1.04 | $20.08B | $20.48B | N/A | ![]() | ![]() | Details | |
| 4/16/25 | Q125 | $4.37 | $4.74 | -$0.37 | $22.21B | $21.6B | N/A | ![]() | ![]() | Details | |
| 1/29/25 | Q424 | $4.01 | $3.53 | +$0.48 | $19.14B | $18.14B | N/A | ![]() | ![]() | Details | |
| 1/22/25 |
Q424 | N/A | $3.53 | N/A | N/A | $18.14B | N/A | N/A | N/A |


